ASHLEY PARKER: Open Payments
NPI 1730725508 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 59 payments from 21 companies in 2025. Trend: 2023 $1,791 · 2024 $1,306 · 2025 $997
Food & beverage: $952Education: $45
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $141 |
| Lilly USA, LLC | 10 | $130 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $88 |
| PFIZER INC. | 4 | $67 |
| Novo Nordisk Inc | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Abbott Laboratories | 2 | $40 |
| Medtronic, Inc. | 1 | $34 |
Products named: REPATHA, Kerendia, REXULTI, MOUNJARO, AIRSUPRA, INJECTAFER, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across AL — which companies pay providers there.
